Advertisement
Advertisement
June 26, 2016
Enrollment Completed for European PLIANT Registry of Jotec's E-liac Stent Graft System
June 27, 2016—Jotec GmbH announced completion of patient enrollment of the PLIANT postmarket registry. PLIANT is studying patients with iliac aneurysms who are undergoing endovascular stenting with a new generation of Jotec’s low-profile E-liac stent graft system.
According to Jotec, more than 45 patients were enrolled and successfully treated with the E-liac stent graft. Patient follow-up will be conducted up to 36 months from the intervention. The study is planned to be completed in early 2019.
According to Jotec, the objectives of the multicenter study are to evaluate the clinical and technical success, as well as the safety and feasibility, of the E-liac device used in endovascular treatment of unilateral or bilateral aortoiliac or isolated common iliac aneurysms. The main target of the study is the exclusion of aneurysms, with primary patency of the internal iliac artery and external iliac artery on the iliac implantation side. The Principal Investigator of the study is Prof. Jan Brunkwall, MD, with the University Hospital Cologne in Germany.
In January 2014, Jotec announced European CE Mark approval for the E-liac device. In August 2014, the company announced commencement of the PLIANT registry.
Advertisement
Advertisement
